PTLA News and Press, Portola Pharmaceuticals Inc. From 05/05/20

NEW YORK, NY / ACCESSWIRE / May 5, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the pr...

SOUTH SAN FRANCISCO, Calif. , May 5, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA) (the "Company" or " Portola ") today announced that it is cancelling its webcast and conference call to discuss the Company's financial results for the first quarter ended March...

NEW YORK , May 5, 2020 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City , is investigating potential claims concerning whether the following proposed mergers are fair to shareholders.  Moore Kuehn may ul...

Gainers: Portola Pharmaceuticals (NASDAQ: PTLA ) +130% . More news on: Portola Pharmaceuticals, Inc., CleanSpark, Inc., Genprex, Inc., Stocks on the move, , Read more ...

NEW YORK , May 5, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) to Alexion Pharmaceuticals, Inc. for $18 per share in cash is fair to Portola shareholders. On behalf of Por...

Portola Pharmaceuticals (NASDAQ: PTLA ) +131%  on being acquired for $18/share. More news on: Portola Pharmaceuticals, Inc., SG Blocks, Inc., MicroVision, Inc., Stocks on the move, , Read more ...

"Andexxa is a strategic fit with our existing portfolio of transformative medicines and is well-aligned with our demonstrated expertise in hematology, neurology and critical care," says Alexion (NASDAQ: ALXN ) CEO Ludwig Hantson. More news on: Alexion Pharmaceuticals, Inc., Portola Ph...

SOUTH SAN FRANCISCO, Calif. , April 23, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA) today announced that it will host a webcast and conference call to discuss the Company's financial results for the quarter ended March 31, 2020 , and provide a general busine...

Athersys (NASDAQ: ATHX ) initiated with Outperform rating and $14 (528% upside) price target at SMBC Nikko. More news on: Athersys, Inc., Livongo Health, Inc., Pfenex Inc., Healthcare stocks news, Stocks on the move, , Read more ...

SOUTH SAN FRANCISCO, Calif. , April 7, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA) today announced that the Centers for Medicare & Medicaid Services (CMS) established a new permanent J-code for Andexxa ® [coagulation factor Xa (recombinant), in...